In March 2025, the company announced new strategies for the immediate-to-customer presenting of its Wegovy weight loss drug. The company recognized a new pharmacy, named NovoCare, which might cost customers $499 each month for access to the drug, a lot less than 50 % the price of the drug by other pharmaceutical distribution networks.[53]This led N